Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Other Non-Current Assets (2016 - 2021)

Phio Pharmaceuticals' Other Non-Current Assets history spans 10 years, with the latest figure at $50000.0 for Q3 2021.

  • For Q3 2021, Other Non-Current Assets rose 177.78% year-over-year to $50000.0; the TTM value through Sep 2021 reached $50000.0, up 177.78%, while the annual FY2020 figure was $50000.0, 0.0% changed from the prior year.
  • Other Non-Current Assets reached $50000.0 in Q3 2021 per PHIO's latest filing, roughly flat from $50000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $50000.0 in Q4 2017 to a low of $18000.0 in Q3 2019.
  • Average Other Non-Current Assets over 5 years is $37687.5, with a median of $50000.0 recorded in 2017.
  • Peak YoY movement for Other Non-Current Assets: plummeted 64.0% in 2020, then surged 177.78% in 2021.
  • A 5-year view of Other Non-Current Assets shows it stood at $50000.0 in 2017, then changed by 0.0% to $50000.0 in 2018, then changed by 0.0% to $50000.0 in 2019, then changed by 0.0% to $50000.0 in 2020, then changed by 0.0% to $50000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Other Non-Current Assets are $50000.0 (Q3 2021), $50000.0 (Q2 2021), and $50000.0 (Q1 2021).